WJCF is an Indian non-profit organisation committed to saving lives by reducing the burden of disease and strengthening government-owned, high-quality health systems. Since 2007, WJCF has combined data-driven approaches and deep public health expertise with strong government partnerships to design, implement, and scale solutions across India’s national and state health programmes. We work for and at the service of governments — supporting the Ministry of Health & Family Welfare and State Departments of Health to build systems that are strong, sustainable, and led by Indian institutions.
As an Indian organisation, WJCF brings an unmatched depth of contextual understanding of India’s health system architecture, policy landscape, and implementation realities across diverse geographies and population groups. This local institutional credibility, combined with global technical rigour, is central to WJCF’s effectiveness as a partner to governments and donors.
Our work is built around four complementary roles: as a Trusted Government Partner, co-designing programmes and strengthening health system architecture; as an Operational Partner, translating strategies into effective on-the-ground delivery; as a Market Shaper, improving the availability and affordability of health commodities; and as an Ecosystem Catalyst, convening governments, development partners, academia, and the private sector to drive solutions at scale.
WJCF’s programme portfolio spans thematic areas like hepatitis, HIV/AIDS, tuberculosis, vector-borne diseases, syphilis, cervical cancer, diabetes, maternal and childhood anaemia, immunisation, under-5 diarrhoea and pneumonia, sexual and reproductive health, Ayushman Bharat Pradhan Mantri – Jan Arogya Yojana (AB PM-JAY), Ayushman Bharat Digital Mission (ABDM), hypoxemia and oxygen, safe drinking water, sickle cell disease, presbyopia, lead poisoning, and cross cutting thematic areas like AI and Health, integrated disease surveillance and climate and health.
We currently support programmes across 19 states and union territories, with teams working at national, state, district, and sub-district levels.
Our people are our greatest asset. WJCF brings together a talented, diverse team of professionals from public health, analytics, consulting, healthcare, the development sector, and academia, all united by a shared commitment to improving health outcomes for the people of India. We are entrepreneurial, action-oriented, and deeply grounded in the communities and systems we work in. Our field teams collectively bring hundreds of years of experience managing public health programmes across the country.
WJCF collaborates with a range of international and domestic partners and donors to advance its mission, including an affiliation with the Clinton Health Access Initiative (CHAI), a global health organisation with which WJCF shares a common mission and values.
Program Overview:
Type 1 Diabetes Mellitus (T1D) is an auto-immune disease characterized by reduced ability to produce insulin in the body. T1D usually develops in children, adolescents, or young adults, leading to a lifetime dependence on insulin for survival. The condition is associated with a significant strain and poor quality of life, and leading to a high financial burden, for people living with Type 1 Diabetes (PLT1D) and their families. However, with access to timely diagnostic, initiation on treatment and proper management of the condition, people living with T1D can lead healthy and productive lives, while achieving life expectancy comparable to the general population.
There are an estimated 9.4 million PLT1D globally, with India having the second highest share accounting for 8%-10% of the global prevalence. Nearly 18% of children and adolescents with T1D (~0.3 million) live in India, the highest in the world. The incidence of T1D in the 0-19 age group is increasing more than any other age group and is estimated to increase from 8.15 per 100,000 in 2024 to 13.95 per 100,000 by 2040. While the burden of T1D has continued to rise over the years, survival has remained poor. Survival rates for children and adolescents with T1D in India is worse compared to countries with similar socio-economic development. On average, a child diagnosed with T1D at the age of 10 years lives only an additional 29 years of healthy life, contributing to premature mortality and poor quality of life.
There is an urgent need to improve access to screening and diagnosis and to ensure initiation and adherence to treatment for T1D. WJCF’s Type 1 Diabetes program aims at strengthening and improving access to quality T1D care in India, with the overall goal of achieving longer, healthier, and more productive lives for People Living with Type 1 Diabetes. The program aims to address critical barriers to delivery of quality T1D care in India by building awareness, improving access to screening, diagnosis, and treatment services, enabling treatment adherence and self-management, and strengthening governance framework for delivery of T1D care.
Position Summary:
WJCF seeks a highly motivated and detail-oriented individual with outstanding credentials and demonstrated analytical and problem-solving abilities for the role of Senior Analyst (Type 1 Diabetes), based in New Delhi. The Sr. Analyst will actively engage and support program implementation work in focus geographies, helping launch new initiatives as well as accelerate ongoing interventions to improve T1D care outcomes. The Analyst will support program implementation at the state level to strengthen data-driven decision-making, generate insights, support implementation, and contribute to the development of high-quality program materials and analyses.
The ideal candidate would bring strong analytical and communication skills, be comfortable working across multiple stakeholders and geographies simultaneously, and carry an ability to synthesize complex programmatic information into clear, actionable outputs. They would be self-driven, intellectually curious, and motivated by the opportunity to inform large-scale public health programs and deliver impact.
Last Date to Apply: 11th July, 2026
Software Powered by iCIMS
www.icims.com